Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Preclinical CRO Companies

Preclinical Contract Research Organizations (CROs) are specialized companies that provide a wide range of research services to pharmaceutical, biotechnology, and medical device companies during the preclinical phase of drug development. This phase involves extensive testing and research before a potential drug or medical device can advance to clinical trials.

*Disclaimer: List of key companies in no particular orderLatest Preclinical CRO Companies Update

Jun 2023:The estimated annual earnings of Laboratory Corp of America Holdings (LH.N) have decreased since the separation of its clinical development company, Fortrea. The lab owner has been struggling with a shortage of lab monkeys because of limitations on animal imports after a Cambodian supplier was accused of smuggling animals into the US. However, the company expects supply problems with non-human primates (NHPs) to be resolved in the third quarter. In addition, the business now expects core operations revenue to expand by 11.3% to 12.6% for the year rather than the initial projection of 9.5% to 11%. The company predicts that COVID testing revenues will fall by 85% to 89% this year compared to its earlier forecast

Sep 2023: The next-generation Clinical Trial Tokenization technology is now available, according to ICON plc, a pioneer in clinical research and healthcare information. ICON's innovative tokenization engine, real-world data access, and advanced clinical analytics know-how offer priceless, long-term therapeutic efficacy and safety insights over the product development lifecycle. Now that operational models are united and smooth, all these aspects are delivered. ICON's next-generation patented Clinical Trial Tokenisation system seamlessly integrates all the necessary components and makes collecting patient data in a covert, consent-based, and non-intrusive way possible. This is made possible by Privacy Protected Record Linkage (PPRL) across time and source. Advanced algorithms and ICON's ability to create multiple tokens enable very accurate (up to 90%) matching of clinical trial participants to the largest ecosystem of real-world data sources in the United States.

List of Preclinical CRO Key companies in the market

IQVIA (U.S.),

PAREXEL International Corporation (U.S.),

Envigo (U.S.),

Charles River (U.S.),

Eurofins Scientific (Luxembourg),

ICON PLC (Dublin),

PRA Health Sciences (U.S.),

Medpace (U.S.),

Laboratory Corporation of America Holdings (U.S.),

Pharmaceutical Product Development, LLC (U.S.),

WuXi AppTec (China)

D. Biosciences (U.S.)

Preclinical CRO Market Highlights:

Preclinical CRO Market Size

Preclinical CRO Market Trends

Preclinical CRO Market Analysis

Preclinical CRO Market Share

Preclinical CRO Market Highlights:

Preclinical CRO Market Trends

Preclinical CRO Market Analysis

Preclinical CRO Market Share

Preclinical CRO Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.